Eu Yan Sang International said wholly-owned subsidiary EYS Ventures has formed a joint venture company called Scyrec with CellResearch Corporation (CRC).
Scyrec will focus on combining EYS’s expertise in natural and traditional wellness with CRC’s stem cell technologies to drive development of innovative solutions in today’s rapidly evolving healthcare and wellness landscape.
CRC, a privately held Singapore biotechnology company is a pioneer in the development of Cord Lining Stem Cells (CLSC) technology for stem cell regenerative medicine and therapy as well as a supplier of high quality low passage primary cell culture systems.
No comments:
Post a Comment